{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:59:44Z","timestamp":1791107984040,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.atherosclerosis.2004.06.018","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T13:15:35Z","timestamp":1095167735000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["IL-6 and the acute phase response in murine atherosclerosis"],"prefix":"10.1016","volume":"177","author":[{"given":"Li","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2004.06.018_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2004.06.018_bib2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nm1102-1218","article-title":"Innate and acquired immunity in atherogenesis","volume":"8","author":"Binder","year":"2002","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2004.06.018_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","article-title":"Inflammatory bio-markers and cardiovascular risk prediction","volume":"252","author":"Blake","year":"2002","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2004.06.018_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2004.06.018_bib5","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/01.ATV.0000079512.66448.1D","article-title":"C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME study","volume":"23","author":"Luc","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2004.06.018_bib6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.ATV.0000022694.16328.CC","article-title":"Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients","volume":"22","author":"Rezaie-Majd","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2004.06.018_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/hc3801.096354","article-title":"Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion","volume":"104","author":"Tomai","year":"2001","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2004.06.018_bib8","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy","volume":"286","author":"Lindmark","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2004.06.018_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2004.06.018_bib10","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","article-title":"C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis","volume":"20","author":"Torzewski","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2004.06.018_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1043-4666(94)90013-2","article-title":"Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions","volume":"6","author":"Seino","year":"1994","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2004.06.018_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.180.4.1243","article-title":"Defective inflammatory response in interleukin 6-deficient mice","volume":"180","author":"Fattori","year":"1994","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2004.06.018_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/MCB.21.5.1621-1632.2001","article-title":"Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver","volume":"21","author":"Alonzi","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2004.06.018_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2004.06.018_bib15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hq0901.095547","article-title":"Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized LDL: a possible role for interleukin-6","volume":"21","author":"Keidar","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2004.06.018_bib16","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.06.018_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions in all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Aterioscler Thromb"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2004.06.018_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(00)00682-1","article-title":"Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice","volume":"156","author":"Elhage","year":"2001","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2004.06.018_bib19","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1074\/jbc.M004074200","article-title":"Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6","volume":"276","author":"Van Lenten","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2004.06.018_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000114526.50618.24","article-title":"C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"Paul","year":"2004","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2004.06.018_bib21","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0022-2275(20)32160-X","article-title":"Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo","volume":"39","author":"Roselaar","year":"1998","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2004.06.018_bib22","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice","volume":"93","author":"Ishibashi","year":"1994","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2004.06.018_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI200111380","article-title":"Lymphocytes are important in early atherosclerosis","volume":"108","author":"Song","year":"2001","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2004.06.018_bib24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.ATV.19.8.1938","article-title":"Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate","volume":"19","author":"Lichtman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"44","key":"10.1016\/j.atherosclerosis.2004.06.018_bib25","doi-asserted-by":"crossref","first-page":"42774","DOI":"10.1074\/jbc.M306022200","article-title":"Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression","volume":"278","author":"Vergnes","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.06.018_bib26","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-\u03b3 potentiates atherosclerosis in apoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2004.06.018_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.18.5.842","article-title":"Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse","volume":"18","author":"Nakashima","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2004.06.018_bib28","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2337\/diacare.26.7.2139","article-title":"Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes","volume":"26","author":"Jain","year":"2003","journal-title":"Diab Care"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2004.06.018_bib29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.ATV.19.5.1223","article-title":"Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet","volume":"19","author":"Merat","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2004.06.018_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mhj.2000.108244","article-title":"Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction","volume":"140","author":"Tomoda","year":"2000","journal-title":"Am Heart J"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004003788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004003788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:29:45Z","timestamp":1758155385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004003788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0021915004003788"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.06.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 and the acute phase response in murine atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}